You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

STK11

Showing 1 - 25 of 65
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastric Type Adenocarcinoma (GAS) With STK11 Mutation Trial in Shanghai (WX390, Toripalimab)

Recruiting
  • Gastric Type Adenocarcinoma (GAS) With STK11 Mutation
  • Shanghai, Shanghai, China
    The Obstetrics & Gynecology Hospital of Fudan University (Shangh
Nov 3, 2023

NSCLC With STK11/LKB1 Mutation Trial in New York (Daratumumab and Hyaluronidase-fihj, Pre-Intervention Medication,

Not yet recruiting
  • Non-small Cell Lung Cancer With STK11/LKB1 Mutation
  • Daratumumab and Hyaluronidase-fihj
  • +2 more
  • New York, New York
    NYU Langone Health
Mar 29, 2023

Non Small Cell Lung Cancer, Solid Tumors, Adult, Endometrial Cancer Trial in Fairfax (TNG260, Pembrolizumab)

Recruiting
  • Non Small Cell Lung Cancer
  • +6 more
  • Fairfax, Virginia
    NEXT Oncology
Jun 7, 2023

Locally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression = 1% and an STK11

Recruiting
  • Locally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutation
  • Montpellier, France
  • +7 more
Dec 19, 2022

NSCLC Trial (Durvalumab, Tremelimumab, Pemetrexed)

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • (no location specified)
Aug 17, 2023

NSCLC Trial in China (JAB 21822)

Recruiting
  • Non-small Cell Lung Cancer
  • JAB 21822
  • Beijing, Beijing, China
  • +20 more
Sep 26, 2022

NSCLC Trial (Bemcentinib, Pembrolizumab, Pemetrexed)

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • (no location specified)
Jul 19, 2022

Factors Influencing Cascade Testing Among Hereditary

Recruiting
  • Breast Carcinoma
  • +8 more
  • Interview
  • +2 more
  • Birmingham, Alabama
  • +1 more
Jun 22, 2022

NSCLC Trial in Worldwide (Sotorasib)

Active, not recruiting
  • Non-small Cell Lung Cancer
  • Birmingham, Alabama
  • +65 more
Nov 29, 2022

Lung Cancer Trial in Houston (Cemiplimab, Kevzara (Sarilumab))

Not yet recruiting
  • Lung Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Jan 19, 2023

Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in

Recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +4 more
  • Adenosine A2B Receptor Antagonist PBF-1129
  • +2 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Feb 1, 2023

NSCLC (NSCLC) Colorectal Cancer (CRC) Pancreatic Ductal Adenocarcinoma Advanced Solid Tumors Trial in Irving, San Antonio,

Not yet recruiting
  • Non-Small Cell Lung Cancer (NSCLC) Colorectal Cancer (CRC) Pancreatic Ductal Adenocarcinoma Advanced Solid Tumors
  • Assigned interventions
  • Irving, Texas
  • +2 more
Nov 7, 2023

Advanced Lung Non-Squamous Non-Small Cell Carcinoma, Recurrent Lung Non-Squamous Non-Small Cell Carcinoma, Stage IV Lung Cancer

Active, not recruiting
  • Advanced Lung Non-Squamous Non-Small Cell Carcinoma
  • +4 more
  • Mobile, Alabama
  • +324 more
Sep 21, 2021

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, NF1 Mutation Positive Malignant Peripheral Nerve Sheath Tumor

Active, not recruiting
  • Advanced Malignant Solid Neoplasm
  • +3 more
  • Pharmacodynamic Study
  • Telaglenastat Hydrochloride
  • Birmingham, Alabama
  • +30 more
Sep 1, 2022

Pancreas Cancer, Exosomes, Extracellular Vesicles Trial

Not yet recruiting
  • Pancreas Cancer
  • +3 more
    • (no location specified)
    Dec 6, 2022

    Germline Mutations Associated With Hereditary Pancreatic Cancer

    Recruiting
    • Pancreatic Cancer
    • Pancreatic Adenocarcinoma
    • Invitae Multi-Cancer Panel ®
    • Mexico City, Mexico
      Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubi
    Mar 22, 2022

    Breast Cancer Female Trial (VTM examination and breast biopsy)

    Not yet recruiting
    • Breast Cancer Female
    • VTM examination and breast biopsy
    • (no location specified)
    Sep 23, 2023

    NSCLC (NSCLC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma Trial in Nashville, San Antonio, Fairfax (RMC-6291)

    Recruiting
    • Non-Small Cell Lung Cancer (NSCLC)
    • +3 more
    • San Antonio, Texas
    • +1 more
    Aug 16, 2022

    Solid Malignancy, Solid Tumor Trial in Saint Louis (Everolimus)

    Completed
    Has Results
    • Solid Malignancy
    • Solid Tumor
    • Saint Louis, Missouri
      Washington University School of Medicine
    Sep 5, 2018

    NSCLC, Non-squamous Non-small-cell Lung Cancer, Non-Squamous Non-Small Cell Tumor of Lung Trial in United States (drug,

    Terminated
    • Non-Small Cell Lung Cancer
    • +5 more
    • Birmingham, Alabama
    • +101 more
    Mar 8, 2022

    Integrated Molecular Profiling in Advanced Cancers Trial

    Active, not recruiting
    • Breast Cancer
    • +9 more
      • Toronto, Ontario, Canada
        Princess Margaret Hospital
      Sep 26, 2022

      Advanced Cancer, Metastatic Cancer, Malignant Neoplastic Disease Trial in Puerto Rico, United States (MRTX849, Pembrolizumab,

      Recruiting
      • Advanced Cancer
      • +2 more
      • Birmingham, Alabama
      • +97 more
      Jan 6, 2023

      Pancreatic Cancer Early Detection Consortium

      Recruiting
      • Pancreas Cancer
      • +3 more
        • Duarte, California
        • +29 more
        Jul 14, 2022

        Frequency of Occult Breast Cancer After Prophylactic Mastectomy

        Recruiting
        • Genetic Predisposition
        • +3 more
        • Histopathological confirmation
        • Karachi, Sindh, Pakistan
          Aga Khan University Hospital
        Mar 15, 2023

        Early Development of Endometrial Carcinoma

        Recruiting
        • Cancer of Endometrium
          • Ferrara, Italy
            Section of Obstetrics and Gynecology, Department of Morphology,
          Apr 4, 2022